Not Signed In - Main Topic Area
All Topic Areas
1 - 10 of 211 more >>
News
1 - 5 of 10 more >>
- Acorda Announces Positive Phase 3 Fampridine-SR Study In People With Multiple Sclerosis
MedicalNewsToday - Thu, 28 Sep 2006 10:00 EST
- SR-BI Provides Protection Outside The Liver
MedicalNewsToday - Mon, 11 Sep 2006 01:00 EST
- Catholic Health Association Of The United States Comments On The Latest Census Bureau's Report On Health Insurance, USA
MedicalNewsToday - Wed, 30 Aug 2006 07:00 EST
- AstraZeneca Submits An NDA For Sustained Release Formulation SEROQUEL SR(TM) For The Treatment Of Schizophrenia
MedicalNewsToday - Mon, 24 Jul 2006 06:00 EST
- AstraZeneca Submits An NDA For Sustained Release Formulation Seroquel SRTM For The Treatment Of Schizophrenia
MedicalNewsToday - Sat, 22 Jul 2006 01:00 EST
Clinical Trials
1 - 5 of 91 more >>
- A Study of Naltrexone SR/Bupropion SR and Placebo in Obese Subjects Participating in a Behavior Modification Program
ClinicalTrials.gov Identifier: NCT00456521 - Active, not recruiting
Obesity
- A Study of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Obese Subjects
ClinicalTrials.gov Identifier: NCT00532779 - Recruiting
Obesity
- A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Type 2 Diabetics
ClinicalTrials.gov Identifier: NCT00474630 - Recruiting
Obesity; Diabetes Mellitus, Type 2
- A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Obesity
ClinicalTrials.gov Identifier: NCT00567255 - Recruiting
Obesity
- Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer''s Disease (AD)
ClinicalTrials.gov Identifier: NCT00151398 - Active, not recruiting
Alzheimer''s Disease
email this page
print this page
bookmark this page
feedback on this page
